ITC Takes On “Anti-Terror” Small Pox Vaccine Patent Dispute
Bavarian Nordic accused U.K.-based Acambis Inc. in August of patent infringement and misappropriation of trade secrets, filing its complaint with the ITC and in the U.S. District Court for the District of Delaware.
The parties are the only two companies working on a specially-weakened, hence safer, version of the smallpox vaccine. Bavarian alleges Acambis is producing its...
To view the full article, register now.